General Information
Project ID
OEP001040
Project Name
Clinical Efficacy and Molecular Biomarkers in a Phase II Study of Tucidinostat Plus R-CHOP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
Description
This is a prospective, single-arm, open-label phase II study of Tucidinostat in combination with R-CHOP in the treatment of de novo, elderly, high-risk diffuse large B cell lymphoma patients.
Project information
Experiments
1
Experiment ID
Experiment name
Experiment type
Create Date
OEX010546
NHL_WGS
Genomic
2020-09-07
Samples
25
Sample ID
Sample Name
Sample Subject Type
Organism
Tissue
Create Date
OES032667
P3
Human
Homo sapiens
Lymphoma
2020-07-01
OES032668
P2
Human
Homo sapiens
Lymphoma
2020-07-01
OES032669
P6
Human
Homo sapiens
Lymphoma
2020-07-01
OES032670
P13
Human
Homo sapiens
Lymphoma
2020-07-01
OES032671
P9
Human
Homo sapiens
Lymphoma
2020-07-01
OES032672
P10
Human
Homo sapiens
Lymphoma
2020-07-01
OES032673
P14
Human
Homo sapiens
Lymphoma
2020-07-01
OES032674
P16
Human
Homo sapiens
Lymphoma
2020-07-01
OES032675
P15
Human
Homo sapiens
Lymphoma
2020-07-01
OES032676
P17
Human
Homo sapiens
Lymphoma
2020-07-01
OES032677
P18
Human
Homo sapiens
Lymphoma
2020-07-01
OES032678
P19
Human
Homo sapiens
Lymphoma
2020-07-01
OES032679
P24
Human
Homo sapiens
Lymphoma
2020-07-01
OES032680
P20
Human
Homo sapiens
Lymphoma
2020-07-01
OES032681
P22
Human
Homo sapiens
Lymphoma
2020-07-01
OES032682
P26
Human
Homo sapiens
Lymphoma
2020-07-01
OES032683
P32
Human
Homo sapiens
Lymphoma
2020-07-01
OES032684
P34
Human
Homo sapiens
Lymphoma
2020-07-01
OES032685
P40
Human
Homo sapiens
Lymphoma
2020-07-01
OES032686
P47
Human
Homo sapiens
Lymphoma
2020-07-01
OES032687
P45
Human
Homo sapiens
Lymphoma
2020-07-01
OES032688
P36
Human
Homo sapiens
Lymphoma
2020-07-01
OES032689
P35
Human
Homo sapiens
Lymphoma
2020-07-01
OES032690
P37
Human
Homo sapiens
Lymphoma
2020-07-01
OES032691
P33
Human
Homo sapiens
Lymphoma
2020-07-01
Runs
50
Run ID
Run Name
Experiment
Sample
Data Num
Create Date
OER066170
WGC109445.bai
OEX010546
OES032667
1
2020-09-07
OER066171
WGC109445.bam
OEX010546
OES032667
1
2020-09-07
OER066172
WGC109444.bai
OEX010546
OES032668
1
2020-09-07
OER066173
WGC109444.bam
OEX010546
OES032668
1
2020-09-07
OER066174
WGC109450.bai
OEX010546
OES032669
1
2020-09-07
OER066175
WGC109450.bam
OEX010546
OES032669
1
2020-09-07
OER066176
DN1706070022.bai
OEX010546
OES032670
1
2020-09-07
OER066177
DN1706070022.bam
OEX010546
OES032670
1
2020-09-07
OER066178
WGC109447.bai
OEX010546
OES032671
1
2020-09-07
OER066179
WGC109447.bam
OEX010546
OES032671
1
2020-09-07
OER066180
DN1706070026.bai
OEX010546
OES032672
1
2020-09-07
OER066181
DN1706070026.bam
OEX010546
OES032672
1
2020-09-07
OER066182
DN1706070027.bai
OEX010546
OES032673
1
2020-09-07
OER066183
DN1706070027.bam
OEX010546
OES032673
1
2020-09-07
OER066184
DN1706070029.bai
OEX010546
OES032674
1
2020-09-07
OER066185
DN1706070029.bam
OEX010546
OES032674
1
2020-09-07
OER066186
DN1706070028.bai
OEX010546
OES032675
1
2020-09-07
OER066187
DN1706070028.bam
OEX010546
OES032675
1
2020-09-07
OER066188
DN1706070021.bai
OEX010546
OES032676
1
2020-09-07
OER066189
DN1706070021.bam
OEX010546
OES032676
1
2020-09-07
OER066190
DN1706070025.bai
OEX010546
OES032677
1
2020-09-07
OER066191
DN1706070025.bam
OEX010546
OES032677
1
2020-09-07
OER066192
DN1706070024.bai
OEX010546
OES032678
1
2020-09-07
OER066193
DN1706070024.bam
OEX010546
OES032678
1
2020-09-07
OER066194
DN1706070031.bai
OEX010546
OES032679
1
2020-09-07
OER066195
DN1706070031.bam
OEX010546
OES032679
1
2020-09-07
OER066196
R18056365.bai
OEX010546
OES032680
1
2020-09-07
OER066197
R18056365.bam
OEX010546
OES032680
1
2020-09-07
OER066198
R18055798.bai
OEX010546
OES032681
1
2020-09-07
OER066199
R18055798.bam
OEX010546
OES032681
1
2020-09-07
OER066200
DN1706070032.bai
OEX010546
OES032682
1
2020-09-07
OER066201
DN1706070032.bam
OEX010546
OES032682
1
2020-09-07
OER066202
R18055790.bai
OEX010546
OES032683
1
2020-09-07
OER066203
R18055790.bam
OEX010546
OES032683
1
2020-09-07
OER066204
R18055776.bai
OEX010546
OES032684
1
2020-09-07
OER066205
R18055776.bam
OEX010546
OES032684
1
2020-09-07
OER066206
R18056356.bai
OEX010546
OES032685
1
2020-09-07
OER066207
R18056356.bam
OEX010546
OES032685
1
2020-09-07
OER066208
R18055792.bai
OEX010546
OES032686
1
2020-09-07
OER066209
R18055792.bam
OEX010546
OES032686
1
2020-09-07
OER066210
R18056364.bai
OEX010546
OES032687
1
2020-09-07
OER066211
R18056364.bam
OEX010546
OES032687
1
2020-09-07
OER066212
R18055757.bai
OEX010546
OES032688
1
2020-09-07
OER066213
R18055757.bam
OEX010546
OES032688
1
2020-09-07
OER066214
R18056366.bai
OEX010546
OES032689
1
2020-09-07
OER066215
R18056366.bam
OEX010546
OES032689
1
2020-09-07
OER066216
R18055784.bai
OEX010546
OES032690
1
2020-09-07
OER066217
R18055784.bam
OEX010546
OES032690
1
2020-09-07
OER066218
R18056367.bai
OEX010546
OES032691
1
2020-09-07
OER066219
R18056367.bam
OEX010546
OES032691
1
2020-09-07
Author Information
Create Date
2020-07-01
Last Modified
2023-09-07
Submission
Ying Fang
State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; National Research Center